A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
- Citation:
- Ann Surg Oncol vol 15 (1) 158-64
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA31946, CA32291, CA33601, CA41287, CA47559, CA60138, CA77658
- Corr. Author:
- Authors:
- Mitchell C Posner Donna Niedzwiecki Alan P Venook Donna R Hollis Hedy L Kindler Edward W Martin Richard L Schilsky Richard M Goldberg Robert J Mayer
- Networks:
- Study
- CALGB-89903
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Aged, 80 and over, Antibodies, Anti-Idiotypic, Cancer Vaccines, Carcinoembryonic Antigen, Chemotherapy, Adjuvant, Colorectal Neoplasms, Disease-Free Survival, Female, Glycolipids, Glycoproteins, Hepatectomy, Humans, Immunity, Cellular, Immunotherapy, Liver Neoplasms, Male, Middle Aged, Prospective Studies, Survival Rate, Treatment Outcome, Vaccination